-- Septerna（股票代碼：SEPN）週一宣布，其試驗性口服甲狀旁腺功能減退症治療藥物SEP-479的I期臨床試驗已完成首批受試者的給藥。 該公司表示，這項安慰劑對照試驗將招募最多150名健康成年人，以評估單次和多次遞增劑量給藥後藥物的安全性和生理代謝。 該公司還表示，將監測受試者血鈣水平和其他生物標記的變化，預計2026年底或2027年初公佈結果。
Price: $23.40, Change: $+0.31, Percent Change: +1.34%
Related Articles
Asia
Jia Yao's Profit Slumps in 2025; Shares Gain 5%
Jia Yao (HKG:1626) posted profit attributable to owners of 1.8 million yuan for 2025, down from 50.6 million yuan a year earlier, according to an April 24 Hong Kong bourse filing.Shares of the paper cigarette packaging supplier were up nearly 5% in Monday morning trade.Earnings per share came in at 0.003 yuan, compared with 0.084 yuan in 2024.Revenue fell 16% year on year to 644.9 million yuan from 770.5 million yuan.
$HKG:1626
Asia
Fiberhome Telecom's 2025 Profit Drops 38%, Revenue Slips 13%
Fiberhome Telecommunication Technologies' (SHA:600498) net profit attributable to shareholders in 2025 dropped 38% to 435.8 million yuan from 702.7 million yuan a year earlier, according to a Shanghai bourse filing on Saturday.The Chinese telecommunications equipment company's shares rose 1% during Monday's morning trade.Earnings per share fell 41% year on year to 0.36 yuan from 0.61 yuan.Operating revenue slipped 13% to 24.9 billion yuan from 28.5 billion yuan in the previous year.
$SHA:600498
Asia
RBL Bank's Consolidated Profit Surges in Fiscal Q4
RBL Bank's (NSE:RBLBANK, BOM:540065) consolidated profit after tax jumped to 2.44 billion Indian rupees in the fiscal fourth quarter ended March 31, from 869.9 million rupees a year ago.Earnings per share climbed to 3.90 rupees from 1.43 rupees a year earlier, according to a Saturday filing to the Indian stock exchanges. The EPS was lower than the 4.39 rupees estimated by analysts polled by Visible Alpha.Interest earned by the lender in fiscal Q4 increased to 37.2 billion rupees from 34.8 billion rupees a year ago.The bank's board proposed a dividend of 1 rupee per share of face value of 10 rupees each.
$BOM:540065$NSE:RBLBANK